Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen:
https://doi.org/10.21256/zhaw-20474| Publikationstyp: | Beitrag in wissenschaftlicher Zeitschrift |
| Art der Begutachtung: | Open peer review |
| Titel: | Comparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trials |
| Autor/-in: | Holper, Lisa Hengartner, Michael Pascal |
| et. al: | No |
| DOI: | 10.1186/s12888-020-02839-y 10.21256/zhaw-20474 |
| Erschienen in: | BMC Psychiatry |
| Band(Heft): | 20 |
| Heft: | 1 |
| Seite(n): | 437 |
| Erscheinungsdatum: | 2020 |
| Verlag / Hrsg. Institution: | BioMed Central |
| ISSN: | 1471-244X |
| Sprache: | Englisch |
| Schlagwörter: | Antidepressants; Bayesian network meta-analysis; Placebo; Side-effects; Unblinding |
| Fachgebiet (DDC): | 615: Pharmakologie und Therapeutik 616.8: Neurologie und Krankheiten des Nervensystems |
| Zusammenfassung: | The issue of unblinded outcome-assessors and patients has repeatedly been stressed as a flaw in allegedly double-blind antidepressant trials. Unblinding bias can for example result from a drug's marked side effects. If such unblinding bias is present for a given drug, then it might be expected that the placebos of that drug are rated significantly less effective than that of other antidepressants. |
| URI: | https://digitalcollection.zhaw.ch/handle/11475/20474 |
| Volltext Version: | Publizierte Version |
| Lizenz (gemäss Verlagsvertrag): | CC BY 4.0: Namensnennung 4.0 International |
| Departement: | Angewandte Psychologie |
| Organisationseinheit: | Psychologisches Institut (PI) |
| Enthalten in den Sammlungen: | Publikationen Angewandte Psychologie |
Dateien zu dieser Ressource:
| Datei | Beschreibung | Größe | Format | |
|---|---|---|---|---|
| 2020_Hopler_Comparative_efficacy_of_placebos_BMC_Psychiatry.pdf | 1.1 MB | Adobe PDF |  Öffnen/Anzeigen |
Zur Langanzeige
Holper, L., & Hengartner, M. P. (2020). Comparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trials. BMC Psychiatry, 20(1), 437. https://doi.org/10.1186/s12888-020-02839-y
Holper, L. and Hengartner, M.P. (2020) ‘Comparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trials’, BMC Psychiatry, 20(1), p. 437. Available at: https://doi.org/10.1186/s12888-020-02839-y.
L. Holper and M. P. Hengartner, “Comparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trials,” BMC Psychiatry, vol. 20, no. 1, p. 437, 2020, doi: 10.1186/s12888-020-02839-y.
HOLPER, Lisa und Michael Pascal HENGARTNER, 2020. Comparative efficacy of placebos in short-term antidepressant trials for major depression : a secondary meta-analysis of placebo-controlled trials. BMC Psychiatry. 2020. Bd. 20, Nr. 1, S. 437. DOI 10.1186/s12888-020-02839-y
Holper, Lisa, and Michael Pascal Hengartner. 2020. “Comparative Efficacy of Placebos in Short-Term Antidepressant Trials for Major Depression : A Secondary Meta-Analysis of Placebo-Controlled Trials.” BMC Psychiatry 20 (1): 437. https://doi.org/10.1186/s12888-020-02839-y.
Holper, Lisa, and Michael Pascal Hengartner. “Comparative Efficacy of Placebos in Short-Term Antidepressant Trials for Major Depression : A Secondary Meta-Analysis of Placebo-Controlled Trials.” BMC Psychiatry, vol. 20, no. 1, 2020, p. 437, https://doi.org/10.1186/s12888-020-02839-y.
Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.